# Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects

> **NCT01176890** · NA · UNKNOWN · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 30 (estimated)

## Conditions studied

- Vagotomy, Truncal

## Interventions

- **DRUG:** GLP-1
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT01176890
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2011-08
- **Final completion:** 2012-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01176890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01176890, "Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT01176890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*